Literature DB >> 11580982

Microparticle vaccine approaches to stimulate mucosal immunisation.

D J Brayden1, A W Baird.   

Abstract

Entrapment of antigens in biodegradable particles for mucosal immunisation has given successful outcomes in animals, but not as yet in man. Formulations using genuinely stable biocompatible nanoparticles with co-entrapped mucosal adjuvants and/or with surface-conjugated human M-cell-targeting ligands may lead to better uptake of intact antigen by Peyer's patch M cells and delivery to antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11580982     DOI: 10.1016/s1286-4579(01)01445-9

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  8 in total

1.  A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation.

Authors:  Ana Beloqui; David J Brayden; Per Artursson; Véronique Préat; Anne des Rieux
Journal:  Nat Protoc       Date:  2017-06-15       Impact factor: 13.491

Review 2.  Mucosal vaccine delivery: Current state and a pediatric perspective.

Authors:  Akhilesh Kumar Shakya; Mohammed Y E Chowdhury; Wenqian Tao; Harvinder Singh Gill
Journal:  J Control Release       Date:  2016-02-06       Impact factor: 9.776

Review 3.  Alginate as a Promising Biopolymer in Drug Delivery and Wound Healing: A Review of the State-of-the-Art.

Authors:  Mohammad A S Abourehab; Rahul R Rajendran; Anshul Singh; Sheersha Pramanik; Prachi Shrivastav; Mohammad Javed Ansari; Ravi Manne; Larissa Souza Amaral; A Deepak
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

4.  The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus.

Authors:  Michael Look; W Mark Saltzman; Joe Craft; Tarek M Fahmy
Journal:  Biomaterials       Date:  2013-11-01       Impact factor: 12.479

5.  In vivo phage display to identify M cell-targeting ligands.

Authors:  Lisa M Higgins; Imelda Lambkin; Graham Donnelly; Daragh Byrne; Carolyn Wilson; Jacqueline Dee; Melanie Smith; Daniel J O'Mahony
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.580

Review 6.  Use of lectin-functionalized particles for oral immunotherapy.

Authors:  Susanne C Diesner; Xue-Yan Wang; Erika Jensen-Jarolim; Eva Untersmayr; Franz Gabor
Journal:  Ther Deliv       Date:  2012-02

Review 7.  Targeting the porcine immune system--particulate vaccines in the 21st century.

Authors:  Kenneth C McCullough; Artur Summerfield
Journal:  Dev Comp Immunol       Date:  2008-09-02       Impact factor: 3.636

8.  [Immunity and antiviral vaccinations. Example: the respiratory mucosa].

Authors:  F Denis; S Hantz; S Alain
Journal:  Antibiotiques (Paris)       Date:  2008-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.